iA Global Asset Management Inc. reduced its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 47.7% during the 4th quarter, HoldingsChannel reports. The firm owned 97,591 shares of the financial services provider’s stock after selling 88,949 shares during the period. iA Global Asset Management Inc.’s holdings in CME Group were worth $26,650,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Canada Post Corp Registered Pension Plan grew its stake in shares of CME Group by 16.2% in the 4th quarter. Canada Post Corp Registered Pension Plan now owns 27,447 shares of the financial services provider’s stock valued at $7,495,000 after purchasing an additional 3,832 shares during the last quarter. Stephens Investment Management Group LLC purchased a new position in shares of CME Group in the 4th quarter valued at approximately $224,000. Stephens Inc. AR grew its stake in shares of CME Group by 48.6% in the 4th quarter. Stephens Inc. AR now owns 3,653 shares of the financial services provider’s stock valued at $998,000 after purchasing an additional 1,194 shares during the last quarter. AlphaCore Capital LLC grew its stake in shares of CME Group by 212.9% in the 4th quarter. AlphaCore Capital LLC now owns 2,522 shares of the financial services provider’s stock valued at $689,000 after purchasing an additional 1,716 shares during the last quarter. Finally, DNB Asset Management AS grew its stake in shares of CME Group by 45.2% in the 4th quarter. DNB Asset Management AS now owns 110,256 shares of the financial services provider’s stock valued at $30,109,000 after purchasing an additional 34,298 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Key Stories Impacting CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, pending regulatory review. The new contract would be CME’s first-ever market-cap weighted futures product and expands its regulated crypto offerings, which investors may view as a growth driver. Article: CME Group to Launch Nasdaq CME Crypto Index Futures
- Positive Sentiment: Reports that Interactive Brokers is integrating CME event contracts into a unified prediction-markets platform highlight CME’s growing relevance in new trading products and could support longer-term volume opportunities. Article: Interactive Brokers Debuts All-in-One Prediction Market Portal
- Positive Sentiment: Coverage of CME’s annual meeting preliminary results was routine governance news, but it showed no apparent disruption to the company’s leadership or shareholder base. Article: CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
- Neutral Sentiment: Multiple reports said CME and Intercontinental Exchange are lobbying U.S. regulators to increase scrutiny of Hyperliquid, arguing that the unregulated platform could affect price discovery in oil and crypto markets. This is more about competitive/regulatory positioning than a direct business event for CME, but it may be seen as CME defending the regulated futures ecosystem. Article: CME, ICE Push US to Curb Crypto’s Offshore Oil Trading Upstart
- Neutral Sentiment: Broader market commentary referenced CME’s FedWatch tool showing higher odds of a Fed hike later in 2026, but this is an indirect macro signal rather than company-specific news. Article: The Bond Market Just Fired A Warning Shot At The AI Rally — Fed Hike Ahead
Wall Street Analyst Weigh In
Check Out Our Latest Report on CME Group
CME Group Stock Performance
NASDAQ CME opened at $298.86 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The business’s 50 day moving average is $298.07 and its two-hundred day moving average is $288.06. CME Group Inc. has a 12-month low of $257.17 and a 12-month high of $329.16. The stock has a market capitalization of $108.29 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 3.61 and a beta of 0.23.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping the consensus estimate of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.80 EPS. Research analysts expect that CME Group Inc. will post 12.26 EPS for the current year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s payout ratio is 44.37%.
Insider Transactions at CME Group
In other news, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the sale, the director owned 43,007 shares of the company’s stock, valued at $13,317,117.55. The trade was a 8.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares in the company, valued at $7,647,194.10. This trade represents a 1.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 7,791 shares of company stock valued at $2,489,421 in the last quarter. 0.30% of the stock is currently owned by corporate insiders.
CME Group Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
